Oncternal Therapeutics (NASDAQ:ONCT) Coverage Initiated at StockNews.com

Research analysts at StockNews.com started coverage on shares of Oncternal Therapeutics (NASDAQ:ONCT – Get Rating) in a research report issued to clients and investors on Wednesday. The brokerage set a “sell” rating on the stock. A number of other research analysts have also recently weighed in on the stock. HC Wainwright cut shares of Oncternal […]

Related Keywords

San Diego ,California ,United States ,Davidf Hale ,Jamesb Breitmeyer , ,Maxim Group ,Goldman Sachs Group Inc ,Oncternal Therapeutics Inc ,Securities Exchange Commission ,Prudential Financial Inc ,Mirabella Financial Services ,Waypoint Capital Advisors ,Richmond Brothers Inc ,Oncternal Therapeutics ,Get Rating ,Capital Acquisition ,Capital Management ,Exchange Commission ,Sachs Group ,Financial Services ,Capital Advisors ,Oncternal Therapeutics Daily ,Nasdaq Onct ,Conct ,Medical ,Initiated Coverage ,Stocknews Com ,